π
|
Bronchoscopic Lung Cryobiopsy Increases Diagnostic Confidence in the Multidisciplinary Diagnosis of Idiopathic Pulmonary Fibrosis.
17 auth.
S. Tomassetti,
A. Wells,
U. Costabel,
A. Cavazza,
T. Colby,
G. Rossi,
N. Sverzellati,
A. Carloni,
E. Carretta,
M. Buccioli,
...
Paola Tantalocco,
C. Ravaglia,
C. Gurioli,
A. Dubini,
S. Piciucchi,
J. Ryu,
V. Poletti
|
8 |
2016 |
8 π
|
π
|
Transbronchial Lung Cryobiopsy in the Diagnosis of Fibrotic Interstitial Lung Diseases
15 auth.
G. Casoni,
S. Tomassetti,
A. Cavazza,
T. Colby,
A. Dubini,
J. Ryu,
E. Carretta,
Paola Tantalocco,
S. Piciucchi,
C. Ravaglia,
...
C. Gurioli,
M. Romagnoli,
C. Gurioli,
M. Chilosi,
V. Poletti
|
8 |
2014 |
8 π
|
π
|
Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment.
12 auth.
G. La Manna,
F. Pizza,
E. Persici,
O. Baraldi,
G. Comai,
M. Cappuccilli,
...
F. Centofanti,
E. Carretta,
G. Plazzi,
L. Colì,
P. Montagna,
S. Stefoni
|
7 |
2011 |
7 π
|
π
|
Incremental prognostic value of changes in B-type natriuretic peptide in heart failure.
12 auth.
R. Latini,
S. Masson,
M. Wong,
S. Barlera,
E. Carretta,
L. Staszewsky,
...
T. Vago,
A. Maggioni,
I. Anand,
L. Tan,
G. Tognoni,
J. Cohn
|
7 |
2006 |
7 π
|
π
|
Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone
13 auth.
S. Salvi,
V. Casadio,
V. Conteduca,
S. Burgio,
C. Menna,
E. Bianchi,
L. Rossi,
E. Carretta,
C. Masini,
D. Amadori,
...
D. Calistri,
G. Attard,
U. Giorgi
|
6 |
2015 |
6 π
|
π
|
Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone
11 auth.
U. de Giorgi,
P. Caroli,
S. Burgio,
C. Menna,
V. Conteduca,
E. Bianchi,
...
F. Fabbri,
E. Carretta,
D. Amadori,
G. Paganelli,
F. Matteucci
|
6 |
2014 |
6 π
|
π¦
|
Hip fracture: effectiveness of early surgery to prevent 30-day mortality
E. Carretta,
V. Bochicchio,
P. Rucci,
G. Fabbri,
M. Laus,
M. Fantini
|
6 |
2011 |
6 π¦
|
π
|
Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial.
10 auth.
L. Staszewsky,
M. Wong,
S. Masson,
S. Barlera,
E. Carretta,
A. Maggioni,
...
I. Anand,
J. Cohn,
G. Tognoni,
R. Latini
|
6 |
2007 |
6 π
|
π
|
Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial
9 auth.
M. Cicoira,
A. Maggioni,
R. Latini,
S. Barlera,
E. Carretta,
A. JΓ‘nosi,
...
J. Soler,
I. Anand,
J. Cohn
|
6 |
2007 |
6 π
|
π
|
Statins and symptomatic chronic systolic heart failure: a post-hoc analysis of 5010 patients enrolled in Val-HeFT.
11 auth.
H. Krum,
R. Latini,
A. Maggioni,
I. Anand,
S. Masson,
E. Carretta,
...
F. Ingrillì,
G. Pettinati,
R. Glazer,
G. Tognoni,
J. Cohn
|
6 |
2007 |
6 π
|